首页 | 本学科首页   官方微博 | 高级检索  
检索        

阿法骨化醇对高血压颈动脉粥样硬化患者血尿酸、C反应蛋白和补体的影响
引用本文:刘爱学,王小娟,吴颖,于常英,梁晓慧.阿法骨化醇对高血压颈动脉粥样硬化患者血尿酸、C反应蛋白和补体的影响[J].实用心脑肺血管病杂志,2010,18(1):6-8.
作者姓名:刘爱学  王小娟  吴颖  于常英  梁晓慧
作者单位:河北省秦皇岛市第一医院风湿免疫科,066000
摘    要:目的观察阿法骨化醇对老年高血压合并颈动脉粥样硬化(CAS)患者血尿酸(BUA)、补体C3和血清C-反应蛋白(CRP)水平的影响。方法随机选择122例老年高血压合并CAS患者分为两组。治疗组:65例患者口服阿法骨化醇加常规药物治疗3月。对照组:57例患者接受常规药物治疗3月。比较治疗前后患者的血压、血糖、血脂、肾功能、CRP、C3和BUA水平的变化。结果阿法骨化醇治疗组患者治疗后CRP、C3和BUA水平明显低于治疗前(P0.05);对照组患者治疗前后CRP、C3和BUA的水平差异无统计学意义(P0.05)。结论阿法骨化醇能够降低老年高血压病合并CAS患者的CRP、C3和BUA水平,可能对防治动脉粥样硬化有着积极的作用。

关 键 词:阿法迪三  动脉粥样硬化  血尿酸  补体C3  C反应蛋白

The Effect of Alfacalcidol on the Serum Levels of CRP,BUA and Complement in Patients with Hypertension and Carotid Artherosclerosis
LIU Ai-xue,WANG Xiao-juan,WU Ying,et al..The Effect of Alfacalcidol on the Serum Levels of CRP,BUA and Complement in Patients with Hypertension and Carotid Artherosclerosis[J].Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease,2010,18(1):6-8.
Authors:LIU Ai-xue  WANG Xiao-juan  WU Ying  
Institution:LIU Ai-xue,WANG Xiao-juan,WU Ying,et al.Department of Comprehensive,NO.1 Hospital of Qin-huangdao,Qinhuangdao 066000,China
Abstract:Objective To observe the effect of Alfacalcidol on the level of C-reactive protein(CRP).C3 and blood uric acid(BUA) in serum of elderly patients with hypertension and carotid artherosclerosis.Methods There were 122 elderly patients with hypertension and carotid artherosclerosis divided into two groups.In treatment group,there were 65 elderly patients who were treated with Alfacalcidol and routine drugs,In control group,there were 57 elderly patients who were treated with routine drugs.The levels of blood ca...
Keywords:Alpha D3  Atherosclerosis  blood uric acid(BUA)  Complement C3  C-reactive protein(CRP)  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号